ENDRA Life Sciences Inc.(NDRA)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

ENDRA Life Sciences Inc. (NDRA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NDRA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.5m in revenue and is scored on the micro-cap board instead. Top institutional holders of NDRA by reported 13-F value include Altium Capital Management, CITADEL ADVISORS, CITIZENS FINANCIAL GROUP, based on the most recent SEC filings. NDRA trades on the Nasdaq exchange and files with the SEC under CIK 1681682. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NDRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ENDRA Life Sciences Inc. directly from SEC EDGAR.

Net Income

$159.9K

NDRA key financials by period

ENDRA Life Sciences Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 201810-K$6.2K$-9.8M
FY 201710-K$351.6K$-5.4M
FY 201610-K$515.6K$-2.8M

Institutions holding NDRA

Institutional investors reporting a position in ENDRA Life Sciences Inc. on SEC Form 13F.
InstitutionSharesValueReported
Altium Capital Management59,272$315.9K2026-06-30
CITADEL ADVISORS29,924$159.5K2026-06-30
CITIZENS FINANCIAL GROUP28,400$151.4K2026-06-30
GEODE CAPITAL MANAGEMENT14,910$79.5K2026-06-30
VANGUARD FIDUCIARY10,121$53.9K2026-06-30
VANGUARD CAPITAL MANAGEMENT7,339$39.1K2026-06-30
MORGAN STANLEY3,546$18.9K2026-06-30
UBS Group AG68$362.002026-06-30
Tower Research Capital (TRC)58$309.002026-06-30
NORTHWESTERN MUTUAL WEALTH MANAGEMENT19$101.002026-06-30
NDRA

ENDRA Life Sciences Inc.

NDRA
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.5M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$159.9K

EPS (Diluted)

Q2 2026
EDGAR

$0.06

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…